Home Applications 218347 Application 218347
Type NDA
Sponsor ABBVIE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 RINVOQ LQ UPADACITINIB SOLUTION;ORAL 1MG/ML Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218347-001 RINVOQ LQ UPADACITINIB 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218347-001 8962629 2031-01-15 U-3945 Drug substance 2024-05-23 N218347-001 8962629 2031-01-15 U-3946 Drug substance 2024-05-23 N218347-001 RE47221 2033-08-16 Drug substance 2024-06-12 N218347-001 10981923 2036-10-17 Drug substance 2024-05-23 N218347-001 11186584 2036-10-17 Drug substance 2024-05-23 N218347-001 11661425 2036-10-17 Drug substance 2024-05-23 N218347-001 11680069 2036-10-17 Drug substance 2024-05-23 N218347-001 11718627 2036-10-17 Drug substance 2024-05-23 N218347-001 11773105 2036-10-17 Drug substance 2024-05-23 N218347-001 12110298 2036-10-17 Drug substance 2024-11-05 N218347-001 12365689 2036-10-17 U-3945 2025-08-20 N218347-001 9951080 2036-10-17 Drug substance 2024-05-23
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N218347-001 NP 2027-04-26 N218347-001 ODE-481 2031-04-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 8072bd15b7f6…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218347-001 RINVOQ LQ 1MG/ML SOLUTION / ORAL RLD, RS 2024-04-26 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 4 · 143 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218347-001 8962629 2031-01-15 U-3946 Drug substance 2024-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 8962629 2031-01-15 U-3945 Drug substance 2024-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 RE47221 2033-08-16 Drug substance 2024-06-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 10981923 2036-10-17 Drug substance 2024-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 11186584 2036-10-17 Drug substance 2024-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 11661425 2036-10-17 Drug substance 2024-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 11680069 2036-10-17 Drug substance 2024-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 11718627 2036-10-17 Drug substance 2024-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 11773105 2036-10-17 Drug substance 2024-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 12110298 2036-10-17 Drug substance 2024-11-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 12365689 2036-10-17 U-3945 2025-08-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218347-001 9951080 2036-10-17 Drug substance 2024-05-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 8962629 2031-01-15 U-3946 Drug substance 2024-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 8962629 2031-01-15 U-3945 Drug substance 2024-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 RE47221 2033-08-16 Drug substance 2024-06-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 10981923 2036-10-17 Drug substance 2024-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 11186584 2036-10-17 Drug substance 2024-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 11661425 2036-10-17 Drug substance 2024-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 11680069 2036-10-17 Drug substance 2024-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 11718627 2036-10-17 Drug substance 2024-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 11773105 2036-10-17 Drug substance 2024-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 12110298 2036-10-17 Drug substance 2024-11-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 12365689 2036-10-17 U-3945 2025-08-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218347-001 9951080 2036-10-17 Drug substance 2024-05-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218347-001 8962629 2031-01-15 U-3946 Drug substance 2024-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 8962629 2031-01-15 U-3945 Drug substance 2024-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 RE47221 2033-08-16 Drug substance 2024-06-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 10981923 2036-10-17 Drug substance 2024-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 11186584 2036-10-17 Drug substance 2024-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 11661425 2036-10-17 Drug substance 2024-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 11680069 2036-10-17 Drug substance 2024-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 11718627 2036-10-17 Drug substance 2024-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 11773105 2036-10-17 Drug substance 2024-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 12110298 2036-10-17 Drug substance 2024-11-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218347-001 9951080 2036-10-17 Drug substance 2024-05-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218347-001 8962629 2031-01-15 U-3946 Drug substance 2024-05-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218347-001 8962629 2031-01-15 U-3945 Drug substance 2024-05-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218347-001 RE47221 2033-08-16 Drug substance 2024-06-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218347-001 10981923 2036-10-17 Drug substance 2024-05-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218347-001 11186584 2036-10-17 Drug substance 2024-05-23 fd3edfee7708…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Rinvoq UPADACITINIB AbbVie Inc. 2966aec7-2ef0-923c-d8ff-fe1a957bf095 2026-06-30 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 218347 application number: NDA218347
Documents# Document, Submission type, Date table Document Submission type Date 85995 SUPPL 2026-05-21 85990 SUPPL 2026-05-21 83759 SUPPL 2025-10-15 83748 SUPPL 2025-10-14 83747 SUPPL 2025-10-14 81951 ORIG 2025-04-11 81770 SUPPL 2025-03-28 81752 SUPPL 2025-03-27 81751 SUPPL 2025-03-27 78299 ORIG 2024-04-29 78289 ORIG 2024-04-29